Association between carotid diameter and the advanced glycation endproduct Nepsilon-Carboxymethyllysine (CML)
Open Access
- 1 January 2009
- journal article
- research article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 8 (1) , 45
- https://doi.org/10.1186/1475-2840-8-45
Abstract
Nε-Carboxymethyllysine (CML) is the major non-cross linking advanced glycation end product (AGE). CML is elevated in diabetic patients and apparent in atherosclerotic lesions. AGEs are associated with hypertension and arterial stiffness potentially by qualitative changes of elastic fibers. We investigated whether CML affects carotid and aortic properties in normoglycemic subjects.Keywords
This publication has 37 references indexed in Scilit:
- Mechanical ventilation during experimental sepsis increases deposition of advanced glycation end products and myocardial inflammationCritical Care, 2009
- Role of TNF-α in vascular dysfunctionClinical Science, 2009
- Fetuin-A and arterial stiffness in patients with normal kidney functionRegulatory Peptides, 2008
- Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin ProductionPLOS ONE, 2008
- Blockade of RAGE Suppresses Alloimmune Reactions In Vitro and Delays Allograft Rejection in Murine Heart TransplantationAmerican Journal of Transplantation, 2007
- Association of serum fetuin‐A with carotid arterial stiffnessClinical Endocrinology, 2006
- Association Between Arterial Properties and Renal Sodium Handling in a General PopulationHypertension, 2006
- Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetesDiabetologia, 2006
- Advanced Glycation End Products Are Associated With Pulse Pressure in Type 1 DiabetesHypertension, 2005
- Nε-(Carboxymethyl)lysine depositions in human aortic heart valves: similarities with atherosclerotic blood vesselsAtherosclerosis, 2004